A potential vaccine against the Ebola virus has been successful in monkeys, reveals a study published in 30 November
The Ebola virus kills nine infected people in 10 and causes severe pain, high fever and extensive internal bleeding. Researchers at the US National Institutes of Health in Maryland showed that the monkeys were able to launch an effective immune response against Ebola virus (
The DNA vaccine has also been designed to include elements of all three known Ebola strains, ensuring its effectiveness against all possible outbreaks. Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases, welcomed the results: "Ebola is a difficult virus because currently available antiviral drugs have no proven effect on it and we do not know its natural reservoir, making environmental control impossible." He added: "A vaccine is therefore the best hope for protecting humans from infection, and this study makes some key advances."